Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2025-06-12

EMA Authorised: Nyxoid (naloxone hydrochloride dihydrate) — Mundipharma Corporation (Ireland) Limited

View source ↗

Summary

EMA has authorised Nyxoid (naloxone hydrochloride dihydrate) for the emergency treatment of opioid overdose. The product is manufactured by Mundipharma Corporat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nyxoid (naloxone hydrochloride dihydrate)

Snippet

Status: Authorised. Therapeutic area: Opiate Overdose. MAH: Mundipharma Corporation (Ireland) Limited. Decision date: 25/04/2025